$Moderna, Inc.(MRNA)$ In 2022, Moderna expects to make between $17 billion and $22 billion in revenue from Spikevax. That's vastly more than its trailing revenue of $11.8 billion, and the global market for coronavirus vaccines is still quite far from being saturated.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论